Filing metadata

Accession number
0000947871-23-000515
Form type
Form 4
Filer
Kinnate Biopharma Inc.
CIK
CIK 1797768
Filed
May 02, 2023
Reporting period
Apr 28, 2023
Description
Insider transaction

Explore SEC Filings Hub